Skip to main content

Reducing Dispensary Expiry Loss: Demand, Reordering and Supplier Returns

Reduce dispensary expiry losses by buying against realistic demand, separating usable stock from stock that cannot be supplied, and acting before supplier return deadlines. Track quantity, batch, expiry, purchase cost and the expected recovery route together. A large discount or bonus quantity can still lose money if the clinic cannot legitimately use the stock in time. Inventory pressure must never determine which medicine a patient is prescribed.

By Bractis · Updated · 8 min read

Indian clinic owners and authorised dispensary staff reviewing purchases, slow-moving stock and supplier credits.

Ask three different questions about every slow-moving item

First, is the item eligible for use or supply under the clinic's authorised process? Second, how much realistic demand exists before the relevant expiry or other use limit? Third, what value can the clinic actually recover through appropriate use, an accepted supplier return or another lawful route? A positive stock balance answers none of these questions by itself.

Keep the medicine identity and pack unit precise. Ten strips, ten boxes and ten tablets are not interchangeable purchasing quantities. If a supplier changes pack size or supplies several batches, record the conversion and each batch's dates. A reorder report built from mixed units can appear accurate while recommending several times the intended purchase.

WHO's 2020 storage guidance describes expiry-based rotation and requires attention to labelled storage conditions. That does not turn every earlier-expiring pack into usable stock. A damaged, recalled or otherwise restricted item needs the appropriate segregation and decision; software colour coding cannot establish its suitability.

Source: WHO: Good storage and distribution practices for medical products, 2020

Base demand on what the clinic can appropriately supply

Start with recent quantities actually issued and examine why that history may be misleading. Stockouts can suppress observed issues; a temporary specialist camp can exaggerate recurring demand. Record these explanations separately from the numeric average. Do not treat a one-month spike as a permanent reason to buy more.

Use a planning period that fits the product's available life, supplier lead time and clinic's service pattern. A weekly visiting specialist creates a different stock rhythm from a daily service. If treatment or procurement practice changes, update the forecast rather than assuming old consumption will continue.

Clinical decisions remain with the responsible professional. Near-expiry exposure is a purchasing and stock-management problem, not a reason to steer patients toward unnecessary medicines or substitutes. The clinic should also preserve legitimate patient choice about where to obtain medicines; a purchase commitment must not become pressure at the consultation desk.

Test the economics of a bonus offer before accepting it

In a fictional purchasing offer, 100 packs cost ₹80 each and ten additional packs are supplied as documented, legally saleable bonus stock. This example does not concern physician samples or other stock whose sale is restricted. The clinic pays ₹8,000 and receives 110 packs. It expects legitimate demand for only 80 before the remaining stock becomes unusable, with no supplier credit available.

At an assumed lawful realised selling price of ₹100 per pack, those 80 sales generate ₹8,000. Once the remaining 30 packs have no recoverable value, the whole purchase has produced no surplus over its ₹8,000 cash cost, before staff, storage and disposal costs. A low apparent cost per received pack did not make the order economical.

If the supplier instead sells 80 packs at ₹80, the purchase costs ₹6,400 and the same 80 sales produce ₹8,000, leaving ₹1,600 before other costs. This simplified comparison assumes identical timing, product suitability and demand. Taxes, accounting valuation and exact bonus-stock treatment need separate professional review; the point is to compare recoverable demand with the total commitment.

Separate the reorder trigger from the quantity you buy

A trigger tells staff when to review replenishment; it does not automatically identify the right order size. Consider a fictional item with expected demand of three packs per day, seven days' supplier lead time and nine packs of additional buffer. The planning trigger is 3 × 7 + 9 = 30 packs. Those assumptions require local observation, not adoption as a standard safety-stock rule.

Suppose eligible on-hand stock is 22 packs, ten are on a confirmed order and four are committed. The defined inventory position is 22 + 10 − 4 = 28 packs, below the example's trigger. Staff should review replenishment, the reliability of the incoming order and expiry exposure. Counting quarantined stock or an unconfirmed purchase request as usable supply would distort that decision.

Choose the quantity using the next review period, supplier minimums, storage capacity and expected use before expiry. If the supplier's minimum creates excess stock, compare a smaller alternative order, different supply frequency or another appropriate source. Repeatedly accepting too much stock and hoping the doctor will prescribe it is not an inventory strategy.

On a narrow screen, scroll the table horizontally to read all columns.

Stock actions require different evidence
StateOperational decisionFinancial follow-through
Usable but slow movingReassess demand and future purchasing.Estimate exposure using actual cost and recovery possibilities.
Near an agreed return deadlineConfirm supplier eligibility and arrange the permitted route.Track accepted quantity, deductions and expected credit.
Dispatched to supplierRetain product and dispatch references.Do not assume a credit has already been posted.
Supplier credit receivedMatch it to the original return and purchase.Reconcile amount, tax treatment and remaining difference.
Unusable or restrictedFollow the authorised segregation and disposition process.Document quantity and accounting treatment; do not leave it as available stock.
Book quantity differs from countInvestigate units, receipts, issues and adjustments.Do not use an unexplained write-off to conceal the cause.

Follow a return through to an accepted credit

Record the supplier's actual terms at purchase: eligible products, notice period, minimum remaining life, packaging condition and what counts as acceptance. A salesperson saying 'we take everything back' is not a reliable recovery assumption. Confirm disputed terms before making a large order, especially when the demand forecast is uncertain.

A return passes through distinct states: proposed, accepted for return, dispatched, received, accepted in quantity and credited. Keep the batch, pack quantity, original purchase reference and financial adjustment connected. A courier delivery receipt confirms a parcel arrived; it does not establish that the supplier accepted all items or the full claimed amount.

ICAI AS 2 uses the lower of cost and net realisable value for inventories within its scope. Ask the CA how this applies to the actual stock and entity. The purchase price printed in the system is not proof of recoverable value, and an expected supplier credit should not be treated as confirmed simply to avoid showing a loss.

Source: ICAI: Accounting Standard 2 — Valuation of Inventories

Review the purchasing cause, not only the write-off

Measure expiry exposure at cost using a clear cutoff, and keep realised losses separate from stock still under review. Do not report the maximum retail value of unusable items as if that entire amount had been spent. Equally, do not call a transfer to a return shelf a saving before the financial recovery is known.

Look for repeat causes: oversized minimum orders, inconsistent units, delayed supplier credits, stockout-distorted forecasts, duplicate ordering or missing batch dates. Give each cause an owner. A monthly report that lists the same items without changing the next purchase has not solved the problem.

Test the process on a small product set before expanding it. Reconcile the physical count, transaction history, usable quantity and proposed order. Keep safety and dispensing authority outside the commercial scoring: a profitable stock position is not evidence that a product may appropriately be supplied to a particular patient.

A fictional return is delivered but not credited in full

The clinic dispatches 12 eligible packs under a supplier-approved return. The supplier records receipt of ten and issues credit for ten. The clinic keeps the two-pack discrepancy open with dispatch evidence rather than marking all 12 recovered. Purchasing decisions use the confirmed credit and the unresolved exposure separately, while the stock ledger records the physical movement accurately.

Review slow stock and purchasing decisions

Use these prompts in your clinic’s own notes. Record the result, responsible person and next action for each item.

Units and eligibility
Choose one slow-moving item and reconcile its pack conversion, physical count, status and eligible quantity.
Demand and offer
Compare a bulk offer with a smaller order using realistic use before expiry and total purchase commitment.
Return evidence
Document the actual deadline and acceptance criteria; trace a return through to the supplier credit.
Cause and next purchase
Identify why the stock accumulated and specify the change to the next ordering decision.

Questions doctors ask

Is FEFO the same as an accounting inventory-cost method?

No. Expiry-based physical rotation concerns which eligible stock is used first. Accounting cost and valuation follow the applicable policy. Keep the physical batch decision and the financial calculation distinct.

Are bonus packs always a better purchase?

No. Compare the full cash commitment with realistic, appropriate demand before the stock becomes unusable. Restricted samples must not be treated as ordinary saleable bonus stock.

Should near-expiry stock count toward the reorder calculation?

Only to the extent the defined planning method can legitimately rely on it. Consider eligibility, remaining life and expected demand; do not let unusable or restricted stock hide a supply gap.

When is a supplier return financially resolved?

When the accepted quantity and credit or other agreed recovery are evidenced and reconciled. Dispatch and delivery are intermediate events, not proof of full credit.

Should doctors prescribe more of a medicine to avoid expiry loss?

No. Clinical need and appropriate prescribing govern patient care. Address excess stock through purchasing, permitted returns and the authorised stock-disposition process.

Sources and scope

Updated on . Original purchasing models and fictional prices. Guidance does not establish pharmacy or dispensing authority, approve a product's clinical use, authorise sample sales or determine tax and accounting treatment. No independent clinical or legal review is claimed.

Try the workflow
with Bractis.

Use a synthetic two-batch item with a pack-size conversion, restricted stock and a partially credited return. Ask Bractis to show the eligible quantity, ordering inputs and the difference between return dispatch and confirmed recovery.

Request a clinic demo